CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 500 filers reported holding CRISPR THERAPEUTICS AG in Q2 2021. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,152,601 | -19.3% | 2,713,210 | -0.2% | 0.00% | 0.0% |
| Q2 2023 | $152,620,801 | +20.6% | 2,718,575 | -2.9% | 0.00% | 0.0% |
| Q1 2023 | $126,579,818 | +18.4% | 2,798,581 | +6.4% | 0.00% | +33.3% |
| Q4 2022 | $106,898,809 | -30.3% | 2,629,737 | +12.1% | 0.00% | -40.0% |
| Q3 2022 | $153,350,000 | +17.3% | 2,346,584 | +9.0% | 0.01% | +25.0% |
| Q2 2022 | $130,785,000 | -8.6% | 2,152,126 | -5.6% | 0.00% | 0.0% |
| Q1 2022 | $143,038,000 | +48.4% | 2,278,774 | +79.2% | 0.00% | +100.0% |
| Q4 2021 | $96,358,000 | -23.8% | 1,271,528 | +12.6% | 0.00% | -50.0% |
| Q3 2021 | $126,399,000 | -25.7% | 1,129,284 | +7.5% | 0.00% | -20.0% |
| Q2 2021 | $170,075,000 | +8.2% | 1,050,548 | -18.6% | 0.01% | 0.0% |
| Q1 2021 | $157,226,000 | -12.5% | 1,290,335 | +10.0% | 0.01% | -16.7% |
| Q4 2020 | $179,640,000 | +86.1% | 1,173,259 | +1.7% | 0.01% | +50.0% |
| Q3 2020 | $96,508,000 | +29.7% | 1,153,843 | +13.9% | 0.00% | +33.3% |
| Q2 2020 | $74,434,000 | +186.1% | 1,012,817 | +65.1% | 0.00% | +200.0% |
| Q1 2020 | $26,019,000 | -32.0% | 613,529 | -2.4% | 0.00% | 0.0% |
| Q4 2019 | $38,283,000 | +51.7% | 628,557 | +2.1% | 0.00% | 0.0% |
| Q3 2019 | $25,238,000 | -10.0% | 615,730 | +3.4% | 0.00% | 0.0% |
| Q2 2019 | $28,041,000 | +30.7% | 595,333 | -0.9% | 0.00% | 0.0% |
| Q1 2019 | $21,450,000 | +17.4% | 600,481 | -6.1% | 0.00% | 0.0% |
| Q4 2018 | $18,264,000 | -42.0% | 639,235 | -9.9% | 0.00% | 0.0% |
| Q3 2018 | $31,471,000 | -9.8% | 709,643 | +19.6% | 0.00% | -50.0% |
| Q2 2018 | $34,876,000 | +33.3% | 593,527 | +3.7% | 0.00% | +100.0% |
| Q1 2018 | $26,156,000 | +101.6% | 572,218 | +3.6% | 0.00% | 0.0% |
| Q4 2017 | $12,974,000 | +21889.8% | 552,558 | +16623.9% | 0.00% | – |
| Q3 2017 | $59,000 | – | 3,304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |